Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Cancer Epidemiology
|
February 28, 2026
Comparing the national cancer waiting times dataset with other linked electronic health records to measure treatment timeliness: A national cohort study of kidney cancer in England
Raghav Varma, Emily Mayne, Marina A Parry, et al.
European Urology
|
December 30, 2020
A Modified Newcastle-Ottawa Scale for Assessment of Study Quality in Genetic Urological Research
Joseph M Norris, Benjamin S Simpson, Rhys Ball, et al.
BMJ Open
|
January 30, 2020
Genetic landscape of prostate cancer conspicuity on multiparametric MRI: a protocol for a systematic review and bioinformatic analysis
Joseph M Norris, Benjamin S Simpson, Marina A Parry, et al.
BJU International
|
October 11, 2019
Genetic correlates of prostate cancer visibility (and invisibility) on multiparametric magnetic resonance imaging: it's time to take stock
Joseph M Norris, Benjamin S Simpson, Marina A Parry, et al.
European Urology Open Science
|
October 1, 2020
Genetic Landscape of Prostate Cancer Conspicuity on Multiparametric Magnetic Resonance Imaging: A Systematic Review and Bioinformatic Analysis
Joseph M Norris, Benjamin S Simpson, Marina A Parry, et al.
European Urology Oncology
|
April 2, 2019
Genomic Evaluation of Multiparametric Magnetic Resonance Imaging-visible and -nonvisible Lesions in Clinically Localised Prostate Cancer
Marina A Parry, Shambhavi Srivastava, Adnan Ali, et al.
The Journal of Clinical Investigation
|
March 31, 2026
Proliferation associates with greater sensitivity to androgen receptor pathway inhibition for metastatic prostate cancer
Larissa Mendes, Peter F Dutey-Magni, Emily Grist, et al.
JCO Precision Oncology
|
January 20, 2022
Genomic Profiles of De Novo High- and Low-Volume Metastatic Prostate Cancer: Results From a 2-Stage Feasibility and Prevalence Study in the STAMPEDE Trial
Clare Gilson, Fiona Ingleby, Duncan C Gilbert, et al.
Cancer Research
|
January 23, 2016
Discordant Haplotype Sequencing Identifies Functional Variants at the 2q33 Breast Cancer Risk Locus
Nicola J Camp, Wei-Yu Lin, Alex Bigelow, et al.
The Lancet. Digital Health
|
June 4, 2025
External validation of a digital pathology-based multimodal artificial intelligence-derived prognostic model in patients with advanced prostate cancer starting long-term androgen deprivation therapy: a post-hoc ancillary biomarker study of four phase 3 randomised controlled trials of the STAMPEDE platform protocol
Charles T A Parker, Larissa Mendes, Vinnie Y T Liu, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Cancer Epidemiology
|
February 28, 2026
Comparing the national cancer waiting times dataset with other linked electronic health records to measure treatment timeliness: A national cohort study of kidney cancer in England
Raghav Varma, Emily Mayne, Marina A Parry, et al.
European Urology
|
December 30, 2020
A Modified Newcastle-Ottawa Scale for Assessment of Study Quality in Genetic Urological Research
Joseph M Norris, Benjamin S Simpson, Rhys Ball, et al.
BMJ Open
|
January 30, 2020
Genetic landscape of prostate cancer conspicuity on multiparametric MRI: a protocol for a systematic review and bioinformatic analysis
Joseph M Norris, Benjamin S Simpson, Marina A Parry, et al.
BJU International
|
October 11, 2019
Genetic correlates of prostate cancer visibility (and invisibility) on multiparametric magnetic resonance imaging: it's time to take stock
Joseph M Norris, Benjamin S Simpson, Marina A Parry, et al.
European Urology Open Science
|
October 1, 2020
Genetic Landscape of Prostate Cancer Conspicuity on Multiparametric Magnetic Resonance Imaging: A Systematic Review and Bioinformatic Analysis
Joseph M Norris, Benjamin S Simpson, Marina A Parry, et al.
European Urology Oncology
|
April 2, 2019
Genomic Evaluation of Multiparametric Magnetic Resonance Imaging-visible and -nonvisible Lesions in Clinically Localised Prostate Cancer
Marina A Parry, Shambhavi Srivastava, Adnan Ali, et al.
The Journal of Clinical Investigation
|
March 31, 2026
Proliferation associates with greater sensitivity to androgen receptor pathway inhibition for metastatic prostate cancer
Larissa Mendes, Peter F Dutey-Magni, Emily Grist, et al.
JCO Precision Oncology
|
January 20, 2022
Genomic Profiles of De Novo High- and Low-Volume Metastatic Prostate Cancer: Results From a 2-Stage Feasibility and Prevalence Study in the STAMPEDE Trial
Clare Gilson, Fiona Ingleby, Duncan C Gilbert, et al.
Cancer Research
|
January 23, 2016
Discordant Haplotype Sequencing Identifies Functional Variants at the 2q33 Breast Cancer Risk Locus
Nicola J Camp, Wei-Yu Lin, Alex Bigelow, et al.
The Lancet. Digital Health
|
June 4, 2025
External validation of a digital pathology-based multimodal artificial intelligence-derived prognostic model in patients with advanced prostate cancer starting long-term androgen deprivation therapy: a post-hoc ancillary biomarker study of four phase 3 randomised controlled trials of the STAMPEDE platform protocol
Charles T A Parker, Larissa Mendes, Vinnie Y T Liu, et al.
Page
of 2